About: http://data.cimple.eu/news-article/537e26f261885b3eb86bc3946df4aae3bad2e54dea149a2b2211a4f3

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/537e26f261885b3eb86bc3946df4aae3bad2e54dea149a2b2211a4f3 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Russia said on Thursday it would start clinical trials of its controversial coronavirus vaccine next week, involving tens of thousands of people. President Vladimir Putin said earlier this month that Russia had become the first country to register a coronavirus vaccine, though the announcement was met with caution from scientists and the World Health Organization who said it still needed a rigorous safety review. Russia's sovereign wealth fund, which finances the vaccine project, said in a statement Thursday that tests of the "immunogenicity and safety of the Sputnik V vaccine" will begin next week involving more than 40,000 people. It said the tests were the equivalent of the Phase 3 trials that other vaccines are undergoing. Kirill Dmitriyev, the head of the Russian Direct Investment Fund, told an online briefing that the vaccination of at-risk groups, including medical personnel, would also start next week on a voluntary basis. More than 20 countries have made requests to purchase over a billion doses of the vaccine, he said, adding that Russia had agreements with several countries to produce it. He said mass vaccinations in Russia are expected to start in October and the first foreign deliveries in November or December. The vaccine -- named after the pioneering 1950s Soviet satellite -- was announced with much fanfare in Russia but drew warnings from Western scientists that Moscow may be moving too quickly. Dmitriyev said scepticism was starting to wane. "We have seen a significant change in tone from the WHO. At first, yes, they did not have enough information on the Russian vaccine, now official information has been sent and they will evaluate it," he said. But he added: "We do not see any obstacle for individual regulators to approve the Russian vaccine without the approval of the WHO." Russia had registered more than 942,000 confirmed coronavirus infections as of Thursday, the fourth-highest number after the United States, Brazil and India, and more than 16,000 deaths. apo-mm/jbr/pch
schema:headline	Russia to test coronavirus vaccine on 40,000 people
schema:mentions	Sovereign wealth fund Sputnik 1 Soviet Union Satellite Moscow President of Russia World Health Organization Russia Vladimir Putin Russian language India Brazil Vaccine United States Severe acute respiratory syndrome coronavirus 2 Dmitriyev (town) Patriarch Kirill of Moscow Russian Direct Investment Fund Immunogenicity
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-08-20 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software